Specialist in Clinical Hematology and Hemotherapy from Faculdade de Conchas in São Paulo and Advanced Aesthetic Health (2017-2019), MBA in Project Management from USP/Esalq (in progress). Master and PhD in Basic and Applied Immunology from the Institute of Biological Sciences (ICB) in the Postgraduate Program in Immunology at the Federal University of Amazonas - UFAM (2016-2022) in partnership with the National Student Mobility Program of the Postgraduate Program degree in Biosciences and Biotechnology (PPGBBio) from the Faculty of Pharmaceutical Sciences of Ribeirão Preto (FCFRP) of the University of São Paulo (USP). Member of the Brazilian Society of Immunology and member of the study group on Lipid Biotechnology and Immunochemistry (GeBiL | FFCLRP-USP). Since 2020, he has been investigating the role of the TREM-1 pathway during SARS-CoV-2 infection. He is currently a Postdoctoral fellow at the Faculty of Philosophy, Sciences and Letters of Ribeirão Preto at the University of São Paulo and at the pathology department at Brigham and Women's Hospital at Harvard Medical School in Boston, Massachusetts, focusing on the investigation of immunological mechanisms innate genes involved in the immunoregulation of TREM-1, glycans and Matrix Metallo-Proteinases (MMPs) in viral infections associated with pathogenesis and search for potential inflammatory biomarkers.My specialties include:Immunoassays, Cell culture, Flow cytometry assays, Zymography, qRT-PCR, Primary Cell Isolation, Slot Blot and Western Blot.